National University of Ireland, Galway-ko ikertzaileekin lankidetzan egindako argitalpenak (6)

2023

  1. The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland

    Acta Diabetologica, Vol. 60, Núm. 2, pp. 211-223

  2. The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening

    Diabetic Medicine, Vol. 40, Núm. 9

2022

  1. The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland

    Journal of Clinical Medicine, Vol. 11, Núm. 13

  2. The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study

    The Journal of clinical endocrinology and metabolism, Vol. 107, Núm. 11, pp. e4311-e4319

  3. The utility of first trimester plasma glycated CD59 (pGCD59) in predicting gestational diabetes mellitus: A prospective study of non-diabetic pregnant women in Ireland

    Diabetes Research and Clinical Practice, Vol. 190

2020

  1. Plasma glycated CD59 predicts early gestational diabetes and large for gestational age newborns

    Journal of Clinical Endocrinology and Metabolism, Vol. 105, Núm. 4, pp. E1033-E1040